Within a short period of time, psychedelics have emerged from the subcultural underground and achieved unprecedented mainstream visibility. The agents of this process are multiple:
OPEN FOUNDATION TALKS
On this page you can find a selection of the best talks from ICPR conferences in 2012, 2016, and 2020 as well as other events organised by the OPEN Foundation such as Opening Up Symposium in 2019, European Ayahuasca Research Symposium in 2011, and Mind Altering Science in 2010.
INTERDISCIPLINARY CONFERENCE ON PSYCHEDELIC RESEARCH 2020
The fourth edition of the Interdisciplinary Conference on Psychedelic Research took place from 24 - 27 September. ICPR 2020 was an academic conference focused on high-quality scientific and scholarly research into psychedelics. Many academic disciplines have important contributions to make within the field of psychedelic studies. ICPR aims to bridge and connect these disciplines, and to facilitate a dialogue between the diverse academic fields and researchers involved in the study of psychedelics.
A panel discussion about the importance of set and setting during psychedelic experiences, including its history. This discussion was moderated by Ioana Pop as part
While western civilization slowly opens up to integrating psychedelics in our medical system, the indigenous cultures of South America represent the oldest living heritage of
INTERDISCIPLINARY CONFERENCE ON PSYCHEDELIC RESEARCH 2016
The Interdisciplinary Conference on Psychedelics Research 2016 (3-5 June) was the third international scientific conference on research into psychedelics organised by the OPEN Foundation. During this three-day event, international researchers from a wide range of academic disciplines presented their latest results and advances in scientific research on psychedelics. ICPR is a multidisciplinary, strictly scientific conference featuring the most current research on psychedelic substances.
Sponsored by the Multidisciplinary Association for Psychedelic studies (MAPS), this Phase II clinical pilot study explores the safety and efficacy of administering MDMA in conjunction
Alicia Danforth – Exploring MDMA-assisted therapy as a new pathway to social adaptability for autistic adults
The first randomized, double-blinded, placebo-controlled Phase 2 study of MDMA-assisted therapy for the treatment of social anxiety in autistic adults is nearing completion. Fear and
This presentation will summarize past and ongoing studies from the Johns Hopkins Psilocybin Research Project, which started about 15 years ago. Laboratory research includes administering
Rick Doblin – Regulatory challenges involved in developing psychedelic-assisted psychotherapy through the FDA/EMA process
This talk will focus on the regulatory challenges involved in developing psychedelic-assisted psychotherapy through the FDA/EMA process. Issues to be discussed will be the initial
Existential distress in reaction to a life-threatening illness is often undertreated and mistreated in western medicine. A randomized clinical trial of psilocybin assisted therapy for
INTERDISCIPLINARY CONFERENCE ON PSYCHEDELIC RESEARCH 2012
On October the 6th & 7th of 2012 OPEN’s second international scientific conference took place in Amsterdam: the Interdisciplinary Conference on Psychedelic Research. In a sold out Mozeskerk over 400 researchers, students, therapists and scholars gathered to listen and discuss the latest psychedelic research. From brain imaging studies on psilocybin, philosophical discussions on the meaning of altered states of consciousness to a debate on the place of MDMA in psychotherapy, ICPR set the standard for future events.
Contemporary esotericism is replete with references to impressive “mystical” or visionary experiences, which are typically credited with having radically changed people’s lives by bringing them into contact with a “spiritual” dimension of reality.
Matthew Johnson – A Systematic Research Program Examining Psilocybin, Mystical Experience, Personality Change, Adverse Effects and Therapeutic Applications
This talk will describe several lines of research with psilocybin conducted by our laboratory at Johns Hopkins (Baltimore, USA). Completed study results to be presented
This talk will describe recently completed fMRI and MEG research with psilocybin and MDMA. I will describe the methods and main results of these studies
THE EUROPEAN AYAHUASCA
RESEARCH SYMPOSIUM 2011
The European Ayahuasca Research Symposium (EARS; June 17th 2011) was a multidisciplinary series of lectures that focused on ayahuasca research in Europe. At the University of Amsterdam, experts from different disciplines presented their studies on ayahuasca’s effects on health, neural functioning and consciousness.
This presentation analyzes from an anthropological perspective some of the ways that ayahuasca’s curative potentials have been portrayed in conventional psychiatry from the 1950s until
Rama Leclerc – The bridge of knowledge: Special links between Shipibo curanderismo and Westerner practices with ayahuasca
The Shipibo-Konibo people from the Peruvian Amazon are part of the Pano ethnolinguistic family. Distributed within more than one hundred villages, the inhabitants live along
Petra Bokor – Integration process and possible therapeutic effects of ayahuasca in non-therapeutic setting
The presentation starts with an overview of the research on the psychotherapeutic effects of ayahuasca and presents in details an investigation into the integration process
Jörg Daumann – Pharmacological modulation of attentional processes in the DMT and ketamine model of psychosis
Deficits in attentional functions are counted among the core cognitive symptoms in schizophrenic patients. Pharmacologic challenges with hallucinogens have been used as models for psychosis.
MIND ALTERING SCIENCE
The Mind Altering Science (MAS) conference was organised on 23 and 24 October 2010 at the University of Amsterdam. With researchers and therapists from a wide variety of academic disciplines, this event was dedicated to the exploration of a broad range of subjects. From addiction treatment to psychotherapy with the aid of psychedelics, from the neurobiology of ayahuasca to the social, ritual, and legal implications of its use, and from human psychopharmacology research and the exploration of exceptional mind states to new views on the legalization of psychedelic substances.
“Molecules of mysticism” are chemical substances that are able to induce mystical experience, increasing the feeling of closeness to the god (entheogens) or to other
Dr. Passie completed his training as a specialist in psychiatry and psychotherapy as well as his academic work at the Psychiatric University Hospital Zurich, in
Psychedelic phenomenology deals with the phenomenal content of psychedelic tripping, thus phenomenology approaches psychedelics from the reverse direction of the scientific approach, because instead of
David Luke – Exploring Exceptional Human Experience on Psychedelics: Ayahuasca, Telepathine and Parapsychology
The Amazonian sacramental decoction, ayahuasca (containing an alkaloid once called telepathine by Westerners), has been used by indigenous shamans and healers for several millennia. Apparently,
How does the psychedelic experience affect the knowledge and motivation of the scientist? And what does this mean for academia in general? To answer such
After more than 40 years the first study employing LSD in psychotherapy is being conducted in Switzerland. 12 persons suffering from a life-threatening disease and
WANT TO ACCESS OUR ENTIRE CONTENT LIBRARY?
When you join the OPEN Foundation's membership programme, you get unlimited access to our content library. A video-on-demand portal of all the best talks, presentations, and webinar series from the past 5 conferences and online events.
INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?
Subscribe to the OPEN Foundation’s newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.